Norris Perne & French LLP Pfizer Inc Transaction History

Norris Perne & French LLP

$1.36 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	SELL	$39.39 - $51.28 $34,426 - $44,818	-874 Reduced 14.98%	4,960 $202,000
Q4 2022 Jan 24, 2023	BUY	$41.75 - $54.5 $243,569 - $317,953	5,834 New	5,834 $0
Q4 2021 Jan 26, 2022	SELL	$41.32 - $61.25 $5,578 - $8,268	-135 Reduced 2.76%	4,756 $281,000
Q3 2021 Oct 26, 2021	SELL	$39.25 - $50.42 $29,437 - $37,815	-750 Reduced 13.3%	4,891 $210,000
Q2 2021 Jul 20, 2021	SELL	$35.91 - $40.68 $29,051 - $32,910	-809 Reduced 12.54%	5,641 $221,000
Q1 2021 Apr 30, 2021	SELL	$33.49 - $37.77 $475,959 - $536,787	-14,212 Reduced 68.78%	6,450 $234,000
Q4 2020 Jan 27, 2021	BUY	$33.47 - $42.56 $970 - $1,234	29 Added 0.14%	20,662 $761,000
Q3 2020 Oct 26, 2020	BUY	$31.75 - $37.25 $62,579 - $73,419	1,971 Added 10.56%	20,633 $757,000
Q2 2020 Jul 23, 2020	BUY	$30.12 - $36.54 $562,099 - $681,909	18,662 New	18,662 $610,000
Q1 2020 Apr 16, 2020	SELL	$27.03 - $38.62 $172,478 - $246,434	-6,381 Closed	0 $0
Q3 2019 Oct 24, 2019	BUY	$32.49 - $42.13 $17,024 - $22,076	524 Added 8.95%	6,381 $229,000
Q2 2019 Jul 19, 2019	SELL	$36.98 - $41.52 $58,613 - $65,809	-1,585 Reduced 21.3%	5,857 $254,000
Q1 2019 Apr 29, 2019	SELL	$37.5 - $41.2 $53,212 - $58,462	-1,419 Reduced 16.01%	7,442 $316,000
Q4 2018 Jan 28, 2019	BUY	$38.47 - $43.86 $14,772 - $16,842	384 Added 4.53%	8,861 $387,000
Q3 2018 Oct 29, 2018	SELL	$34.47 - $41.81 $15,132 - $18,354	-439 Reduced 4.92%	8,477 $374,000
Q2 2018 Jul 24, 2018	BUY	$32.98 - $35.16 $5,111 - $5,449	155 Added 1.77%	8,916 $323,000
Q1 2018 Apr 17, 2018	SELL	$31.91 - $37.02 $13,146 - $15,252	-412 Reduced 4.49%	8,761 $311,000
Q4 2017 Jan 23, 2018	BUY	$33.26 - $35.29 $60,732 - $64,439	1,826 Added 24.85%	9,173 $332,000
Q3 2017 Nov 01, 2017	BUY	$31.0 - $34.15 $227,757 - $250,900	7,347	7,347 $262,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$13.4 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.1 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$7.53 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.36 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.41 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norris Perne & French LLP, based on Form 13F filings with the SEC.

News

Stay updated on Norris Perne & French LLP with notifications on news.

Account